Found 42 clinical trials
Study Seeking Patients with Schizophrenia
Study Seeking Patients with Schizophrenia
- 69 views
- 07 Nov, 2020
- 6 locations
A Phase 3 study to evaluate weight gain of investigational medication compared to olanzapine in adults with schizophrenia
A Phase 3 study to evaluate weight gain of investigational medication compared to olanzapine in adults with schizophrenia
- 186 views
- 23 Nov, 2020
- 1 location
Research studying weight effects of treatment for Schizophrenia in Adults
Research studying weight effects of treatment for Schizophrenia in Adults
- 376 views
- 23 Nov, 2020
- 1 location
Study Seeking Patients with Schizophrenia
Study Seeking Patients with Schizophrenia
- 236 views
- 25 Mar, 2021
- 1 location
Study Seeking Patients with Schizophrenia
Study Seeking Patients with Schizophrenia
- 254 views
- 25 Mar, 2021
- 1 location
Olanzapine in OUD Patients
This study is designed to examine whether olanzapine (2.5 to 20mg/day) impacts opioid use in patients with opioid use disorder and comorbid SMI symptoms who are taking buprenorphine-naloxone
- 0 views
- 21 Jul, 2022
- 2 locations
Intranasal Insulin and Olanzapine Study in Healthy Volunteers (INI/OLA)
, cognition. Preliminary data in rat models has demonstrated that the AP olanzapine (OLA) inhibits the ability of a central insulin stimulus (acting at the level of the brain) to decrease endogenous glucose
- 379 views
- 23 Feb, 2022
- 1 location
Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients
The objective of this study is to investigate the efficacy of olanzapine as compared to neurokinin-1 receptor antagonists (NK1-RAs) in the prevention of chemotherapy-induced nausea and vomiting
- 0 views
- 25 Mar, 2022
- 1 location
Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer
Standard antiemetic therapy without dexamethasone for the prevention of nausea and vomiting in patients with breast cancer
- 0 views
- 03 May, 2022
- 2 locations
Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder
To evaluate the safety, tolerability, and pharmacokinetics of olanzapine and samidorphan in clinically stable pediatric subjects (10 to 12 years old) with Bipolar I disorder following oral
- 0 views
- 16 Oct, 2021
- 1 location